Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg Sells 65,236 Shares

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 65,236 shares of the stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total value of $52,188.80. Following the sale, the chief executive officer now directly owns 895,580 shares of the company’s stock, valued at approximately $716,464. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Leslie Trigg also recently made the following trade(s):

• On Monday, January 13th, Leslie Trigg sold 33,227 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total transaction of $26,913.87.
• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $4,516.00.

Outset Medical Stock Performance

Shares of NASDAQ OM opened at $0.78 on Thursday. Outset Medical, Inc. has a 52 week low of $0.44 and a 52 week high of $5.22. The firm has a 50-day moving average price of $1.01 and a 200 day moving average price of $1.28. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12.

Institutional Investors Weigh In On Outset Medical

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Personalized Indexing Management LLC purchased a new position in Outset Medical during the 2nd quarter valued at about $49,000. National Bank of Canada FI grew its position in shares of Outset Medical by 79.2% in the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after purchasing an additional 23,164 shares during the last quarter. Huntington National Bank increased its stake in shares of Outset Medical by 46.2% during the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after purchasing an additional 20,000 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Outset Medical during the 2nd quarter worth approximately $259,000. Finally, Squarepoint Ops LLC lifted its stake in Outset Medical by 74.1% in the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock valued at $309,000 after buying an additional 34,187 shares in the last quarter.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reissued a “sector perform” rating and set a $3.00 target price on shares of Outset Medical in a research note on Tuesday, January 7th.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.